« European Medicines Agency (EMA) Warns Xeljanz Increases Risk Of Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) | Main | Lemtrada Use Restrictions Issued By EMA’s Pharmacovigilance Risk Assessment Committee Due To Safety Issues »

November 13, 2019

Comments

My Photo

Have A Possible Case?

Quick Contact Form

  • In a rush? You can use our Quick Contact Form to tell us the basic facts about your case.

Current Drug Injury Cases

Drug Safety Developments

Patient Advisory

  • The prescription drugs discussed on this site are approved for use by the the Food and Drug Administration (FDA). Patients should not stop taking any prescription drug without seeking the advice of their medical doctor. This site is not affiliated with any of the drug companies or the FDA.

Get New Posts By Email

RSS Feed

  • FeedBurner

Blog Archives

Disclaimer


  • Please understand that the Drug Injury Watch website is for general information purposes only, and should not be regarded as medical advice or legal advice.... (For more, please see the About page.)

Thank You For Reading